Uses of Virnagza

Used exclusively for men, Virnagza is prescribed for subjects with erectile dysfunction. To ensure the effectiveness when using Virnagza, users need to follow the instructions of their doctors, and consult more information about the uses of Virnagza.

1.1. What is Virnagza? Virnagza belongs to the group of drugs that relax muscles and increase muscle tone.
Virnagza drug includes the following ingredients:
Main active ingredient: Tadalafil 10mg Excipients: Corn starch, lactose, PVP K30 (Polyvinylpyrrolidone), talc, magnesium stearate, DST (Sodium starch glycolate), PEG 6,000, HPMC 615 (Hydroxypropyl methylcellulose), tartrazine color, titanium diokside. The drug is prepared in the form of 10mg yellow filter-coated tablets and 20mg blue filter-coated tablets. Virnagza is recommended for use in men 18 years of age and older.
1.2. What diseases does Virnagza treat? Penile erection is caused by increased blood volume from dilation of penile arteries and smooth muscle. Sexual stimulation leads to smooth muscle relaxation and increased blood flow into the penile tissue, which in turn leads to an erection. In the absence of sexual arousal, tadalafil has no effect. Virnagza is used by doctors to treat erectile dysfunction of the penis, the state of inability to achieve and maintain an erection sufficient for intercourse.
Contraindications:
Patients who are allergic to the main active ingredient tadalafil or any of the excipients of Virnagza. Do not use Virnagza concurrently with any organic nitrate compounds. Hypersensitivity: Virnagza should not be used in patients who are hypersensitive to tadalafil or any of its ingredients. Children under 18. Patients with severe liver failure Patients taking alpha-blocker antihypertensive drugs (doxazosin, tamsulosin...) Congenital retinopathy including retinitis pigmentosa Patients with stroke, infarction heart rate, low blood pressure. Patients who have been advised by their doctors not to engage in sexual activity.

2.1. How to use Virnagza Drugs Virnagza oral use Virnagza 10mg tablets: used with meals or outside meals, because the drug has an immediate effect, it should be taken 30 minutes before sex. Virnagza 20mg tablets: take 3 to 4 hours before sex. 2.2. Dosage of Virnagza The usual dose of Virnagza is 10mg at least 30 minutes before intercourse. Dosage may be increased to 20 mg once daily or decreased to 5 mg once daily depending on individual response. Absolutely NOT used more than 1 time / day and also NOT used daily. Usual dose of Virnagza 20mg: Men should take 1 pill at least 3 to 4 hours before sex for the drug to have an erection effect. The effect of the drug lasts for 10 hours after being used, so it is only used once a day and it is recommended to take it every 3 to 5 days. For patients with renal impairment:
The dose must be reduced for patients with severe renal impairment, the dose should not exceed 5 mg/time per day. No dose reduction is necessary in patients with mild renal impairment.
Handling missed doses:
Medicines need to be used exactly as directed to be effective, so missed doses are limited.
Treatment of Overdose:
Symptoms of Virnagza overdose are similar to adverse events (even at a dose of 100 mg).
The main treatment is hemodialysis to remove the drug from the body.

The dose must be reduced in patients with impaired liver and kidney function (specifically in the dose section) The benefits of treatment and the side effects brought to the patient must be considered when used for those with impaired kidney function. severe liver function. Caution should be exercised in patients with anatomical abnormalities or blood supply disorders, as this may lead to penile erection. Patients with a history of dizziness or visual disturbances should avoid driving or operating machinery while taking Virnagza. Cardiovascular disease: Physicians should consider the patient's cardiovascular status before deciding to administer this drug to a patient. If the patient has penile pain for more than 4 hours, it must be reported to the doctor immediately for timely treatment. The safety and efficacy of Virnagza and other erectile dysfunction drugs have not been evaluated. Recommended for use by men, so not for pregnant and lactating women.

Common: Headache, red face, stuffy nose, back pain, muscle pain, indigestion, pain in extremities.
Uncommon:
Cardiovascular system: chest pain, angina pectoris, hypotension or hypertension, orthostatic hypotension, palpitations, palpitations. Gastrointestinal: nausea, vomiting, lower abdominal pain, gastritis. Musculoskeletal: neck pain, joint pain. Nervous system: dizziness, somnolence, insomnia, paresthesia. Respiratory: pharyngitis, nosebleeds Skin: rash, pruritus, sweating. Eyes: blurred vision, eye pain, lacrimation, conjunctivitis, eyelid swelling. Urinary and genitourinary: increased degree of erection, urinary tract infection

Virnagza with the main active ingredient Tadalafil is metabolised in the liver by CYP3A4, therefore, co-administration with other CYP3A4 inhibitors will increase plasma concentrations of tadalafil and lead to an increased risk of hypotension. Therefore, if the drugs listed above are used concurrently with Virnagza, the dose of Virnagza should not exceed 10 mg/time for 72 hours.
Co-administration of Virnagza with CYP3A4 inducers reduces tadalafil plasma concentrations, thereby reducing the drug's potency
Antacids (aluminum hydroxide, magnesium hydroxide) reduce the absorption of tadalafil into the body leading to decreased effects use of drugs.
Active ingredient Tadalafil enhances the hypotensive effect of nitrate derivatives, so Virnagza should not be used concurrently with nitrate derivatives.

The shelf life of Virnagza is 36 months from the date of manufacture. Store in a cool, dry place, at a temperature not exceeding 30°C, in the original packaging and out of direct sunlight. Keep out of reach of children and pets. Above is all important information about Virnagza drug, before using, patients need to carefully read the instructions and consult a doctor, a specialist pharmacist to achieve the best treatment results.